Gene_set	Pathway	Overlap	P-value	Adjusted P-value	Odds Ratio	Combined Score	Genes
KEGG_2021_Human	Pancreatic cancer	4/76	1.4558243895816926e-06	8.589363898531987e-05	74.03703703703704	-172.05130589538587	SMAD4;TGFB1;TGFBR1;VEGFA
KEGG_2021_Human	AGE-RAGE signaling pathway in diabetic complications	4/100	4.3860489555289296e-06	0.00012938844418810343	55.361111111111114	-136.84140632930726	SMAD4;TGFB1;TGFBR1;VEGFA
KEGG_2021_Human	Chronic myeloid leukemia	3/76	9.159620399517935e-05	0.0018013920119051936	46.93737769080235	-88.55605413655218	SMAD4;TGFB1;TGFBR1
KEGG_2021_Human	Colorectal cancer	3/86	0.0001324740846980751	0.0019539927492966077	41.230636833046475	-79.65388581050792	SMAD4;TGFB1;TGFBR1
KEGG_2021_Human	TGF-beta signaling pathway	3/94	0.00017260861398757182	0.0020367816450533476	37.56828885400314	-73.71479219141467	SMAD4;TGFB1;TGFBR1
KEGG_2021_Human	MAPK signaling pathway	4/294	0.0003034351122757725	0.002267214905541635	17.880459770114943	-49.762697732575255	RASA1;TGFB1;TGFBR1;VEGFA
KEGG_2021_Human	Cytokine-cytokine receptor interaction	4/295	0.0003074189702429336	0.002267214905541635	17.81672394043528	-49.58458596249444	ACVRL1;GDF2;TGFB1;TGFBR1
KEGG_2021_Human	Th17 cell differentiation	3/107	0.0002534260244380865	0.002267214905541635	32.81868131868132	-65.71442008901244	SMAD4;TGFB1;TGFBR1
KEGG_2021_Human	Relaxin signaling pathway	3/129	0.00043986806704120836	0.002715229582163105	27.01360544217687	-55.40965280021221	TGFB1;TGFBR1;VEGFA
KEGG_2021_Human	FoxO signaling pathway	3/131	0.0004602084037564585	0.002715229582163105	26.584821428571427	-54.62268457986884	SMAD4;TGFB1;TGFBR1
KEGG_2021_Human	Gastric cancer	3/149	0.0006711090600743852	0.003599584958580793	23.25440313111546	-48.37496566440217	SMAD4;TGFB1;TGFBR1
KEGG_2021_Human	Hippo signaling pathway	3/163	0.0008721049172913414	0.003958014624629934	21.182142857142857	-44.35724000081694	SMAD4;TGFB1;TGFBR1
KEGG_2021_Human	Hepatitis B	3/162	0.000856615716023289	0.003958014624629934	21.318059299191376	-44.62403509135876	SMAD4;TGFB1;TGFBR1
KEGG_2021_Human	Hepatocellular carcinoma	3/168	0.0009522461559574535	0.004013037371534982	20.527272727272727	-43.06507884394289	SMAD4;TGFB1;TGFBR1
KEGG_2021_Human	Human T-cell leukemia virus 1 infection	3/219	0.0020484263518845244	0.008057143650745797	15.579365079365079	-32.91284230349772	SMAD4;TGFB1;TGFBR1
KEGG_2021_Human	Pathways in cancer	4/531	0.0028173482711087343	0.010388971749713458	9.539531941808981	-25.060320343159585	SMAD4;TGFB1;TGFBR1;VEGFA
KEGG_2021_Human	Adherens junction	2/71	0.0032750085301139972	0.010734750182040323	28.981884057971016	-37.08506032826052	SMAD4;TGFBR1
KEGG_2021_Human	Renal cell carcinoma	2/69	0.0030959091544989293	0.010734750182040323	29.854477611940297	-38.032897794694755	TGFB1;VEGFA
KEGG_2021_Human	Rheumatoid arthritis	2/93	0.005556617161068888	0.017254758552792866	21.914835164835164	-29.03004575134454	TGFB1;VEGFA
KEGG_2021_Human	Chagas disease	2/102	0.006650847322673755	0.01961999960188758	19.92	-26.61700675496218	TGFB1;TGFBR1
KEGG_2021_Human	Cell cycle	2/124	0.009704304916610982	0.027250824307450974	16.2827868852459	-22.027132854342252	SMAD4;TGFB1
KEGG_2021_Human	Osteoclast differentiation	2/127	0.010161324318032567	0.027250824307450974	15.886	-21.510038502238015	TGFB1;TGFBR1
KEGG_2021_Human	Apelin signaling pathway	2/137	0.011753397776716717	0.03015002038375158	14.690740740740742	-19.931093924152265	SMAD4;TGFBR1
KEGG_2021_Human	Cellular senescence	2/156	0.015062699357834773	0.03702913592134381	12.847402597402597	-17.429441058365175	TGFB1;TGFBR1
KEGG_2021_Human	Proteoglycans in cancer	2/205	0.025220492252545426	0.055111446033340006	9.685960591133005	-12.928804077098514	TGFB1;VEGFA
KEGG_2021_Human	Focal adhesion	2/201	0.02430775457262447	0.055111446033340006	9.885678391959798	-13.221635183162709	VEGFA;VWF
KEGG_2021_Human	Diabetic cardiomyopathy	2/203	0.024762333575826773	0.055111446033340006	9.784825870646767	-13.073912909097736	TGFB1;TGFBR1
KEGG_2021_Human	Ras signaling pathway	2/232	0.03174764714886429	0.06689682792082119	8.519565217391305	-11.194266119915625	RASA1;VEGFA
KEGG_2021_Human	Bladder cancer	1/41	0.04963848036556211	0.10098863246786773	22.3	-12.692261742471414	VEGFA
KEGG_2021_Human	Intestinal immune network for IgA production	1/48	0.05788809587819119	0.11173920824734483	18.962174940898347	-11.032973182262484	TGFB1
KEGG_2021_Human	Human papillomavirus infection	2/331	0.06060431633754296	0.11173920824734483	5.880699088145897	-7.115618067766183	VEGFA;VWF
KEGG_2021_Human	Malaria	1/50	0.060233261208856796	0.11173920824734483	18.183673469387756	-10.63265628196324	TGFB1
KEGG_2021_Human	PI3K-Akt signaling pathway	2/354	0.06828569708469599	0.12208654933324437	5.480113636363637	-6.479364551821025	VEGFA;VWF
KEGG_2021_Human	VEGF signaling pathway	1/59	0.07072162222736704	0.12272281504160751	15.344827586206897	-9.124402207995153	VEGFA
KEGG_2021_Human	Inflammatory bowel disease	1/65	0.07765521083230079	0.13090449826016418	13.895833333333334	-8.322075559905016	TGFB1
KEGG_2021_Human	Leishmaniasis	1/77	0.09138288226635771	0.14976639038097514	11.68421052631579	-7.04872976578505	TGFB1
KEGG_2021_Human	Complement and coagulation cascades	1/85	0.10043221696214563	0.16014867029098898	10.56084656084656	-6.37671991533167	VWF
KEGG_2021_Human	Hypertrophic cardiomyopathy	1/90	0.10604677818396174	0.16042974135522417	9.961298377028713	-6.010407578745034	TGFB1
KEGG_2021_Human	ECM-receptor interaction	1/88	0.10380474953181053	0.16042974135522417	10.192848020434228	-6.152535327455873	VWF
KEGG_2021_Human	Dilated cardiomyopathy	1/96	0.11274260878642009	0.16629534795996964	9.32514619883041	-5.615549699272252	TGFB1
KEGG_2021_Human	Amoebiasis	1/102	0.11939326812281527	0.17180982485966098	8.764576457645765	-5.262086311101535	TGFB1
KEGG_2021_Human	HIF-1 signaling pathway	1/109	0.1270956407872156	0.17853911443918383	8.189300411522634	-4.893732148578802	VEGFA
KEGG_2021_Human	Toxoplasmosis	1/112	0.13037805537365837	0.17889082016385685	7.964964964964965	-4.748494648054986	TGFB1
KEGG_2021_Human	Platelet activation	1/124	0.14339691916847833	0.19228223252136867	7.177055103884372	-4.231046804704064	VWF
KEGG_2021_Human	Fluid shear stress and atherosclerosis	1/139	0.15942370386618251	0.20902218951343932	6.384863123993559	-3.698840756963446	VEGFA
KEGG_2021_Human	Signaling pathways regulating pluripotency of stem cells	1/143	0.163651680714637	0.2099010687426866	6.2018779342723	-3.57415842622014	SMAD4
KEGG_2021_Human	Non-alcoholic fatty liver disease	1/155	0.17622102470306392	0.22121362675491002	5.70995670995671	-3.235678410841787	TGFB1
KEGG_2021_Human	Wnt signaling pathway	1/166	0.1875932968535885	0.23058342738253584	5.321885521885521	-2.9652743858654524	SMAD4
KEGG_2021_Human	Axon guidance	1/182	0.2038826300760579	0.24058150348974833	4.841620626151013	-2.6265948500338347	RASA1
KEGG_2021_Human	Tuberculosis	1/180	0.20186266926868635	0.24058150348974833	4.896958410924891	-2.6658400097237527	TGFB1
KEGG_2021_Human	Neutrophil extracellular trap formation	1/189	0.21091631211370437	0.24384064691329385	4.657210401891253	-2.4954112144854435	VWF
KEGG_2021_Human	Kaposi sarcoma-associated herpesvirus infection	1/193	0.21491040066934372	0.24384064691329385	4.55787037037037	-2.4244944960200487	VEGFA
KEGG_2021_Human	Rap1 signaling pathway	1/210	0.23168307497366095	0.2579113476121886	4.178096757044125	-2.1518791496475385	VEGFA
KEGG_2021_Human	Human cytomegalovirus infection	1/225	0.24621391857748554	0.26901150363095644	3.890873015873016	-1.9442968935376908	VEGFA
KEGG_2021_Human	Coronavirus disease	1/232	0.25290994493508406	0.269637202908805	3.7696007696007694	-1.8563524399324505	VWF
KEGG_2021_Human	Chemical carcinogenesis	1/239	0.2595523897792453	0.269637202908805	3.6554621848739495	-1.7734497985532327	VEGFA
KEGG_2021_Human	Calcium signaling pathway	1/240	0.2604969587424048	0.269637202908805	3.6397024639702464	-1.7619943041292825	VEGFA
KEGG_2021_Human	Endocytosis	1/252	0.27174750318495006	0.2764328049640009	3.4603806994245243	-1.6315316807371463	TGFBR1
KEGG_2021_Human	MicroRNAs in cancer	1/310	0.3239838755949599	0.3239838755949599	2.7900035958288387	-1.143955577607994	VEGFA
